Gene: UMAD1

729852
RPA3-AS1|RPA3OS
UBAP1-MVB12-associated (UMA) domain containing 1
protein-coding
7p21.3
Ensembl:ENSG00000219545 Vega:OTTHUMG00000152007 UniprotKB:C9J7I0
NC_000007.14
SNP Mapped
6   ANCO-SNPs
AD
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
2.862e-1 (AD)  5.755e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs2024372chr7:7743288 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)
rs10486187chr7:7739693 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs13237260chr7:7739460 (GRCh38.p7)G>Talcohol dependenceSNV(Single Nucleotide Variation)
rs4720751chr7:7729732 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)
rs10264890chr7:7680356 (GRCh38.p7)T>Galcohol dependenceSNV(Single Nucleotide Variation)
rs1557997chr7:7664329 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UMAD1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UMAD1 mRNA"27188386
D016572CyclosporineCyclosporine results in increased expression of UMAD1 mRNA27989131
D003907DexamethasoneDexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of UMAD1 mRNA]27941970
C000944dicrotophosdicrotophos results in decreased expression of UMAD1 mRNA28302478
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UMAD1 mRNA"27188386
C012589trichostatin Atrichostatin A results in decreased expression of UMAD1 mRNA26272509
D014635Valproic AcidValproic Acid affects the expression of UMAD1 mRNA25979313

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal